Jason Reiser appointed CEO of Market Performance Group
“MPG’s future is bright, and I look forward to leading the team in delivering innovative, results-driven solutions,” Jason Reiser said.
“MPG’s future is bright, and I look forward to leading the team in delivering innovative, results-driven solutions,” Jason Reiser said.
Nourish My Health reaches millions of Americans, particularly in regions with high rates of diet-related diseases.
Retailers and manufacturers face an increasingly complex landscape influenced by inflation, tariffs, weather conditions, and political developments.
This webinar will cover key nonfood trends, including collaboration, emerging products, and health-driven purchasing behaviors.
Kroger's second layoff wave in a month follows nationwide non-store position cuts in February, though specific figures weren't disclosed.
Despite the positive Q4 performance, Ulta warned of a challenging year ahead.
RILA warns that stacked tariffs might unintentionally raise the costs of everyday household goods.
“These findings reinforce the impact of innovative partnerships in improving health outcomes,” says the NACDS Foundation president.
The initiative seeks to revise the FDA’s “Generally Recognized as Safe” (GRAS) Final Rule.
The new stores will average under 5,000 square feet, less than half the size of a typical CVS. Twelve stores are set to open in the U.S. next year.
"This acquisition is a critical step in driving our Digestive Health platform and solidifying our leadership in the healthcare and OTC CPG industry," says Quest Products CEO.
The study's authors stress that misleading promotion of medical tests can lead to overdiagnosis.
The legislation by Reps. Dunn and Mullin aims to cut red tape, expedite generic approvals, and save $800 million over a decade.
NielsenIQ reports that consumers are embracing digital-first wellness solutions at an unprecedented rate.
“By whatever means, the consensus PBM reforms are long overdue and need to be enacted now. The negative impacts of inaction are mounting for Americans and for their pharmacies.”
The transaction, unanimously approved by the WBA Board of Directors, is expected to close in the fourth quarter of 2025.